Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension. (2021)
Attributed to:
Capacity Building in Redox Biology
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1161/hypertensionaha.121.17041
PubMed Identifier: 34304582
Publication URI: http://europepmc.org/abstract/MED/34304582
Type: Journal Article/Review
Volume: 78
Parent Publication: Hypertension (Dallas, Tex. : 1979)
Issue: 3
ISSN: 0194-911X